These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3349170)

  • 1. [Immunomodulating action of myelopeptides in severe closed experimental craniocerebral injury in rats].
    Lisianyĭ NI; Radzhievskiĭ AA; Zakharova LA
    Biull Eksp Biol Med; 1988 Mar; 105(3):310-1. PubMed ID: 3349170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelopeptides effect on longevity and immunological parameters in mice with congenital immunodeficiency.
    Mikhailova AA; Sorokin SV; Komponiec NA
    Ann Ist Super Sanita; 1991; 27(1):57-60. PubMed ID: 1958029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow immunoregulatory peptides (myelopeptides): isolation, structure, and functional activity.
    Petrov RV; Mikhailova AA; Fonina LA
    Biopolymers; 1997; 43(2):139-46. PubMed ID: 9216250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of myelopeptides on the synthesis of DNA and total protein in the cells of the lymphoid organs in the mouse].
    Strelkov LA; Stepanenko RN; Mikhaĭlova AA
    Biull Eksp Biol Med; 1987 Dec; 104(12):703-6. PubMed ID: 3689965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of bone marrow mediator myelopeptides on the summation-threshold index and behavioral reactions of rats].
    Vasilenko AM; Barashkov GN; Zakharova LA
    Biull Eksp Biol Med; 1984 Dec; 98(12):696-8. PubMed ID: 6509198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of various kanamycin dosage forms in experimental nonpenetrating infected injuries to the cornea].
    Verzin AA
    Antibiotiki; 1979 Apr; 24(4):285-6. PubMed ID: 443790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunomodulating action of myelopeptides in hypoxic hypoxia in animals].
    Sarybaeva DV; Zakharova LA; Vasilenko AM; Mikhaĭlova AA; Tulebekov BT
    Biull Eksp Biol Med; 1988 Dec; 106(12):691-2. PubMed ID: 3207877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of myelopeptides on physiological and pathological pain].
    Kryzhanovskiĭ GN; Petrov RV; Grafova VN; Danilova EI; Zakharova LA
    Biull Eksp Biol Med; 1986 Aug; 102(8):181-3. PubMed ID: 3742031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation by opioids in the immunostimulatory activity of myelopeptides.
    Zakharova LA; Belevskaya RG; Yanovskii OG
    Biomed Sci; 1990 Feb; 1(2):139-43. PubMed ID: 2102777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correction of immunity disorder developing after craniocerebral trauma].
    Romodanov AP; Lisianyĭ NI; Kurganova LV
    Biull Eksp Biol Med; 1989 Aug; 108(8):231-3. PubMed ID: 2804331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulating activity of myelopeptides: clinical trials.
    Petrov RV
    Ann N Y Acad Sci; 1993 Jun; 685():351-61. PubMed ID: 8363240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The analgesic effect of various fractions of the supernatant of a bone marrow cell culture in pathologic pain].
    Grafova VN; Danilova EI; Zakharova LA; Mikhaĭlova AA
    Biull Eksp Biol Med; 1988 Dec; 106(12):653-5. PubMed ID: 3207866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of high and low molecular soluble factors of the bone marrow on antibody formation and pain sensitivity in animals].
    Ianovskiĭ OG; Zakharova LA; Vasilenko AM
    Biull Eksp Biol Med; 1990 Jan; 109(1):55-7. PubMed ID: 2334799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The protective properties of myelopeptides in the development of infectious processes caused by bacteria of the genus Salmonella].
    Petrov RV; Aprikian VS; Sergeev IuO; Elkina SI; Sergeev VV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):62-4. PubMed ID: 3046197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endogenous immunoregulatory peptides (myelopeptides): structure, function, and mechanism of action].
    Petrov RV; Mikhaĭlova AA; Fonina LA
    Bioorg Khim; 1999 Nov; 25(11):811-5. PubMed ID: 10645485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelopeptides: bone marrow regulatory mediators.
    Petrov RV; Mikhailova AA; Fonina LA
    Biosci Rep; 1995 Feb; 15(1):1-14. PubMed ID: 7647288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of bone marrow opioid peptides on antibody formation in the productive phase of the immune response].
    Zakharova LA; Belevskaia RG; Mikhaĭlova AA
    Biull Eksp Biol Med; 1988 Jan; 105(1):50-3. PubMed ID: 2962648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunomodulating therapy with myelopid in experimental Salmonella infection].
    Osmanova LIa; Gurariĭ NI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Aug; (8):94-7. PubMed ID: 2686306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelopeptides inhibit development of hereditary macrocytic anemia in W/Wv mice].
    Petrov RV; Kompaniets NA; Man'ko VM; Mikhaĭlova AA
    Dokl Akad Nauk SSSR; 1990; 310(1):247-9. PubMed ID: 2338049
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of a synthetic thymus peptide (thymogen) on the immune system in candidiasis under immunodepression].
    Khmel'nitskiĭ OK; Iakovlev GM; Belianin VL; Khavinson VKh; Morozov VG; Deĭgin VI
    Arkh Patol; 1990; 52(1):20-5. PubMed ID: 2337388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.